Tadashi Tsukamoto
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 39
- Liver Disease and Transplantation 13
- Urology top 2%
-
- Gallbladder and Bile Duct Disorders 17
- Prostate Cancer Treatment and Research 16
- Cancer Research top 5%
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 17
-
- Liver Disease Diagnosis and Treatment 29
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 22
- Pediatric Hepatobiliary Diseases and Treatments 18
- Co-authors
- Shoji KuboKazuhiro HirohashiHiroaki KinoshitaHiromu TanakaY KumamotoNaoya MasumoriTaichi ShutoHideyuki Akaza
- Journals
- Journal of Clinical Oncology (2 papers)Neurology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- JapanUnited StatesSwitzerland
In The Last Decade
Tadashi Tsukamoto
212 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 143
- Hepatology 891
- Urology 215
- Pulmonary and Respiratory Medicine 1.1k
- Cancer Research 426
- Oncology 631
Countries citing papers authored by Tadashi Tsukamoto
This map shows the geographic impact of Tadashi Tsukamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadashi Tsukamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadashi Tsukamoto more than expected).
Fields of papers citing papers by Tadashi Tsukamoto
This network shows the impact of papers produced by Tadashi Tsukamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadashi Tsukamoto. The network helps show where Tadashi Tsukamoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tadashi Tsukamoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 24 | |
| 8 | 2022 | 52 | |
| 9 | 2018 | 12 | |
| 10 | [Clinical experience of imatinib mesylate for metastatic or recurrent gastrointestinal stromal tumor]. | 2014 | 1 |
| 11 | 2014 | 0 | |
| 12 | 2013 | 1 | |
| 13 | 2011 | 1 | |
| 14 | 2011 | 0 | |
| 15 | 2010 | 2 | |
| 16 | 2010 | 0 | |
| 17 | 2010 | 2 | |
| 18 | 2009 | 0 | |
| 19 | 2009 | 2 | |
| 20 | 1995 | 1 |
About Tadashi Tsukamoto
Tadashi Tsukamoto is a scholar working on Hepatology, Urology and Pulmonary and Respiratory Medicine, having authored 247 papers that have together received 4.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (39 papers), Liver Disease Diagnosis and Treatment (29 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (22 papers), Pediatric Hepatobiliary Diseases and Treatments (18 papers), Gallbladder and Bile Duct Disorders (17 papers), Pancreatic and Hepatic Oncology Research (17 papers), Prostate Cancer Treatment and Research (16 papers) and Liver Disease and Transplantation (13 papers). The work is most often cited by research in Hepatology (891 citations), Urology (215 citations) and Pulmonary and Respiratory Medicine (1.1k citations). Tadashi Tsukamoto has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Shoji Kubo, Kazuhiro Hirohashi, Hiroaki Kinoshita, Hiromu Tanaka, Y Kumamoto, Naoya Masumori, Taichi Shuto, Hideyuki Akaza, Takatsugu Yamamoto and Takashi Ikebe. Their work appears in journals such as Journal of Clinical Oncology, Neurology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.